Bivalent boosted: A person is considered "bivalent boosted" if they have received a dose of bivalent vaccine AND at least 14 days has passed since they received their bivalent booster.Vaccinated without a bivalent booster also includes anyone who has received any number of monovalent boosters.
#CASE CORONA USA SERIES#
Vaccinated without a bivalent booster: A person is considered "vaccinated without a bivalent booster" if they have received at least a complete primary series of their vaccine AND at least 14-days have passed since the completion of their primary series.
#CASE CORONA USA PLUS#
This includes children who have a received a primary series plus additional booster doses. Vaccinated with at least a primary series (pediatric data only): A child is considered "vaccinated with at least a primary series" if they have received the complete primary series of their vaccine AND at least 14-days have passed since they have completed their primary series.Unvaccinated: A person is considered "Unvaccinated" if they have not had any COVID-19 vaccines 14 or more days before their infection.Case and vaccine totals reflect only the results from laboratory testing and vaccinations that have been reported to the Minnesota Department of Health.ĭata may not align exactly with the cases reported on other pages or dashboards due to differences in reporting lags and the frequency with which the data are updated.
COVID-19 Vaccine Breakthrough DataĪll data is preliminary and may change as cases are investigated. More about cases can be found in Cases & Variants. ** The 14-day lag for booster doses aligns with the case definition for vaccine breakthrough in a boosted person used in the CDC: COVID Data Tracker. * Partially vaccinated people or people who received only a single dose of Pfizer, Moderna, or Novavax vaccines are excluded from these analyses.
Bivalent booster doses must have been received on or after for people age 12 years and older and on or after for age 5 – 11 years based on when the FDA first authorized bivalent booster doses for each group.
Vaccine breakthrough after a bivalent booster (bivalent boosted):Ī confirmed or probable SARS-CoV-2 infection occurring 14 or more days** after a person has received a booster dose with an FDA-authorized or approved bivalent COVID-19 vaccine. The primary series requires one dose of vaccine for the Janssen (Johnson & Johnson) vaccines or two doses for the Pfizer, Moderna, or Novavax vaccines. Case Definition Vaccine breakthrough after primary series* but no bivalent booster (vaccinated without bivalent booster):Ī confirmed or probable SARS-CoV-2 infection occurring 14 or more days after the most recent dose of an FDA-authorized or approved COVID-19 monovalent vaccine (primary series or booster dose) in any person who completed at least a primary vaccine series but has not received a bivalent booster.
0 kommentar(er)
